In a 40‑year‑old man with type 1 diabetes, weight 73 kg, mild acute kidney injury (creatinine 1.24 mg/dL, eGFR 75 mL/min), currently receiving insulin glargine (Lantus) 14 U daily and a fixed‑meal rapid‑acting insulin aspart (Novolog) regimen totaling 56 U per day, who was given dexamethasone 36 hours ago and is now on an intravenous insulin infusion of 2.5 U per hour, what should his insulin glargine dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) be?

Insulin Dosing Recommendation Post-Dexamethasone

For this patient transitioning off insulin drip after dexamethasone exposure, start Lantus at 30 units daily (50% of calculated total daily dose from IV insulin), use an insulin-to-carbohydrate ratio of 1:10, and an insulin sensitivity factor of 1:50.

Rationale for Basal Insulin Dose

Your patient is currently receiving 2.5 units/hour on IV insulin, which translates to 60 units over 24 hours. When transitioning from IV to subcutaneous insulin in hospitalized patients, guidelines recommend calculating the total daily dose from the average insulin infusion rate over the preceding 12 hours 1.

However, critical adjustments are needed for this specific clinical scenario:

Dexamethasone Effect Consideration

• Dexamethasone was given 36 hours ago, meaning the hyperglycemic effect is likely peaking or beginning to wane (dexamethasone's hyperglycemic effect typically peaks 8-12 hours post-dose and can last 24-48 hours)
• Recent evidence shows that insulin requirements for dexamethasone-induced hyperglycemia are substantially higher than traditional formulas and current practice often underdoses basal insulin initially 2, 3
• The patient's pre-dexamethasone total daily dose was 56 units (14 Lantus + 42 Novolog), but IV requirements jumped to 60 units/day

Acute Kidney Injury Impact

• This is the critical safety consideration: With Cr 1.24 and eGFR 75, insulin clearance is reduced
• Insulin glargine requirements show a strong inverse relationship with declining renal function - at eGFR <60, glargine doses are approximately 30% lower than at eGFR >90 4
• While this patient's eGFR is 75 (not yet <60), the acute nature of the kidney injury creates unpredictable insulin pharmacokinetics 5
• AKI can cause prolonged hypoglycemia with long-acting insulins due to impaired clearance 5

Dose Calculation

Starting with 60 units/24h from IV insulin:

• Allocate 50% to basal insulin = 30 units 1
• This represents a conservative increase from home Lantus (14 units) but accounts for ongoing dexamethasone effect
• The 50% allocation (rather than higher) provides safety margin given AKI

Give Lantus 30 units once daily, preferably in the evening to match the typical afternoon/evening peak of dexamethasone hyperglycemia.

Insulin-to-Carbohydrate Ratio (ICR)

Using the "500 rule": 500 ÷ total daily dose = grams of carbohydrate covered by 1 unit

• With estimated TDD of 60 units: 500 ÷ 60 = 8.3, round to 1:10 ratio
• This means 1 unit of Novolog covers 10 grams of carbohydrate
• This is more aggressive than his pre-admission regimen (which was essentially fixed-dose, not carb-counting)

Insulin Sensitivity Factor (ISF)

Using the "1800 rule" for rapid-acting insulin: 1800 ÷ total daily dose = mg/dL drop per 1 unit

• With TDD of 60 units: 1800 ÷ 60 = 30, but adjust to 1:50 for safety
• This means 1 unit of Novolog lowers blood glucose by approximately 50 mg/dL
• The more conservative 1:50 factor (rather than 1:30) is essential given the AKI and risk of impaired insulin clearance 4, 5

Prandial Insulin Distribution

Allocate remaining 50% of TDD (30 units) across meals:

• Breakfast: 12 units (40% of prandial - accounts for dawn phenomenon and dexamethasone timing)
• Lunch: 10 units (33% of prandial)
• Dinner: 8 units (27% of prandial)

These are starting doses to be adjusted with correction insulin using the ISF above.

Critical Monitoring Requirements

Basal-bolus insulin carries 4-6 times higher hypoglycemia risk than sliding scale alone 1, and this risk is amplified by:

• AKI reducing insulin clearance 4, 5
• Waning dexamethasone effect over next 12-24 hours
• Type 1 diabetes with no endogenous insulin production

Specific Actions:

• Check blood glucose before each meal and at bedtime (minimum)
• If glucose <100 mg/dL pre-meal: hold prandial insulin and recheck in 1 hour
• If AKI worsens (rising Cr): reduce all insulin doses by 20-30% immediately 4
• After 36-48 hours (when dexamethasone effect fully resolves): anticipate need to reduce basal insulin by 30-40%, potentially back toward home dose of 14 units

Common Pitfalls to Avoid

1. Do not use the full 60 units/day from IV insulin - this would cause severe hypoglycemia once dexamethasone effect wanes
2. Do not continue fixed-meal dosing - this patient needs carb-counting and correction doses given the dynamic situation 1
3. Do not ignore the AKI - even "mild" AKI (eGFR 75) significantly alters insulin glargine pharmacokinetics 4
4. Do not wait for severe hyperglycemia to escalate doses - dexamethasone-induced hyperglycemia requires more assertive initial dosing 3

The regimen balances the competing risks of persistent hyperglycemia from dexamethasone against hypoglycemia from AKI-impaired insulin clearance, with a bias toward safety given the acute kidney injury 1, 4, 5.